ArticleThe Journal of international medical research2025
Fatal cardiac complications in two patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: A dual case report.
Article in The Journal of international medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac involvement in idiopathic inflammatory myopathies is typically subclinical; however, it is an important predictor of poor prognosis. Although data are limited, including two small cohorts and several case reports, evidence has demonstrated that cardiac involvement in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis is a significant independent predictor of mortality. Here, we summarized the characteristics of two patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis who developed fatal cardiac complications, one at early stage and the other during long-term follow-up of the disease. Despite aggressive treatment of the primary condition and intensive life support, both patients ultimately succumbed to their cardiac events. These cases highlight the importance of cardiac evaluation and monitoring in patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.